Upexi (NASDAQ:UPXI) Issues Earnings Results

Upexi (NASDAQ:UPXI) posted its quarterly earnings data on Monday. The company reported ($0.07) earnings per share for the quarter, missing the consensus estimate of ($0.04) by ($0.03), MarketWatch Earnings reports. Upexi had a negative net margin of 20.99% and a negative return on equity of 45.15%.

Upexi Stock Performance

Upexi stock opened at $1.00 on Tuesday. The business’s 50-day simple moving average is $1.41 and its 200 day simple moving average is $2.07. The company has a current ratio of 1.30, a quick ratio of 0.71 and a debt-to-equity ratio of 0.58. Upexi has a 12-month low of $0.89 and a 12-month high of $4.94.

Wall Street Analysts Forecast Growth

Separately, Alliance Global Partners decreased their price target on shares of Upexi from $5.00 to $4.00 in a research note on Wednesday, October 4th.

Institutional Trading of Upexi

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. BlackRock Inc. bought a new stake in shares of Upexi during the first quarter worth approximately $71,000. Renaissance Technologies LLC acquired a new stake in Upexi during the 1st quarter worth $54,000. Geode Capital Management LLC bought a new stake in shares of Upexi during the 1st quarter valued at $246,000. Finally, Walleye Capital LLC acquired a new position in shares of Upexi in the 2nd quarter valued at $290,000. 3.39% of the stock is owned by institutional investors.

Upexi Company Profile

Upexi, Inc manufactures and sells various branded products in the health, wellness, pet, beauty, and other markets. The company was formerly known as Grove, Inc and changed its name to Upexi, Inc in August 2022. The company was incorporated in 2018 and is headquartered in Clearwater, Florida.